logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12741926 B1

PDFFull Text
Date of Patent:
Sep. 22, 2026

Filed:

Dec. 18, 2020

Lipoxygenase inhibitors

Applicant:

Sri International, Menlo Park, CA (US);

Inventors:

Ling Jong, Menlo Park, CA (US);

Nathan Collins, Menlo Park, CA (US);

Raymond Ng, Menlo Park, CA (US);

Assignee:

SRI International, Menlo Park, CA (US);

Attorney:

Dicke, Billig & Czaja, PLLC

Primary Examiner:

David K O'dell

Int. Cl.
CPC ...
C07C 217/86 (2006.01); C07C 211/53 (2006.01); C07C 211/54 (2006.01); C07C 211/56 (2006.01); C07C 217/92 (2006.01); C07D 209/14 (2006.01); C07D 213/74 (2006.01); C07D 215/38 (2006.01); C07D 249/08 (2006.01); C07D 295/13 (2006.01); C07D 305/08 (2006.01); C07D 309/04 (2006.01); C07D 401/12 (2006.01); C07D 403/06 (2006.01); C07D 403/12 (2006.01); C07D 405/06 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 409/12 (2006.01); C07D 413/12 (2006.01);
U.S. Cl.
CPC ...
C07C 217/86 (2013.01); C07C 211/53 (2013.01); C07C 211/54 (2013.01); C07C 211/56 (2013.01); C07C 217/92 (2013.01); C07D 209/14 (2013.01); C07D 213/74 (2013.01); C07D 215/38 (2013.01); C07D 249/08 (2013.01); C07D 295/13 (2013.01); C07D 305/08 (2013.01); C07D 309/04 (2013.01); C07D 401/12 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 405/06 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01);
Abstract

Various embodiments of the present disclosure are directed to compounds having Formula I, Formula II, Formula IIA, Formula III, Formula IIIA, Formula IIIB, and/or pharmaceutically acceptable salts thereof. The compounds can be suitable for inhibiting lipoxygenases and/or treating associated diseases. In some embodiments, subject compounds are used to prepare a composition that is effective in treating neurodegenerative diseases.

Find Patent Forward Citations

Quick Actions:

Jong, Ling. (2026). Lipoxygenase inhibitors (U.S. Patent No. 12741926). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12741926

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…